The Ultra-High Efficacy Seeker: Patients needing the absolute maximum weight reduction to meet surgical qualification criteria or to reverse severe comorbidities
Retatrutide alone at lower doses (2 to 4 mg weekly) can produce 15 to 20 pounds of weight loss within 12 to 16 weeks for most people
The dual actions of GLP-1 RAs, namely, the promotion of insulin secretion and the inhibition of glucagon release, exert a significant influence on the plasma ratio of these hormones, thereby contributing to the maintenance of glucose homeostasis in the body
Compounded Semaglutide Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone GLP-1, stimulating insulin secretion, suppressing glucagon, and, critically for weight management, sending satiety signals to the hypothalamus
Clinicians assess sleep quality, stress levels, and activity patterns during monthly visits to identify modifiable barriers to your weight loss
While take-up is uncertain, interest in the program among potentially eligible Medicare beneficiaries is likely to be strong
